Search Results

There are 13115 results for: content related to: Concepts of Risk in Nanomedicine Research

  1. Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 716–750, Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel and Samuel Wickline

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00703.x

  2. You have free access to this content
    Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications

    Journal of Internal Medicine

    Volume 276, Issue 6, December 2014, Pages: 579–617, R. M. Kannan, E. Nance, S. Kannan and D. A. Tomalia

    Version of Record online : 31 JUL 2014, DOI: 10.1111/joim.12280

  3. MSN Anti-Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition

    Advanced Materials

    Volume 26, Issue 3, January 22, 2014, Pages: 391–411, Qianjun He and Jianlin Shi

    Version of Record online : 20 OCT 2013, DOI: 10.1002/adma.201303123

  4. Functional Nanomaterials for Multifarious Nanomedicine

    Biosensors Nanotechnology

    Ravindra P. Singh, Jeong-Woo Choi, Ashutosh Tiwari, Avinash Chand Pandey, Pages: 141–197, 2014

    Published Online : 4 JUL 2014, DOI: 10.1002/9781118773826.ch6

  5. A Portrait of Nanomedicine and Its Bioethical Implications

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 763–779, Rebecca M. Hall, Tong Sun and Mauro Ferrari

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00705.x

  6. Reality Check for Nanomaterial-Mediated Therapy with 3D Biomimetic Culture Systems

    Advanced Functional Materials

    Volume 26, Issue 23, June 20, 2016, Pages: 4046–4065, Chor Yong Tay, Madaswamy S. Muthu, Sing Ling Chia, Kim Truc Nguyen, Si-Shen Feng and David Tai Leong

    Version of Record online : 18 APR 2016, DOI: 10.1002/adfm.201600476

  7. Utility and Potential Application of Nanomaterials in Medicine

    Biomedical Materials and Diagnostic Devices

    Ravindra P. Singh, Jeong -Woo Choi, Ashutosh Tiwari, Avinash Chand Pandey, Pages: 215–262, 2012

    Published Online : 16 OCT 2012, DOI: 10.1002/9781118523025.ch7

  8. Informatics and standards for nanomedicine technology

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 3, Issue 5, September/October 2011, Pages: 511–532, Dennis G. Thomas, Fred Klaessig, Stacey L. Harper, Martin Fritts, Mark D. Hoover, Sharon Gaheen, Todd H. Stokes, Rebecca Reznik-Zellen, Elaine T. Freund, Juli D. Klemm, David S. Paik and Nathan A. Baker

    Version of Record online : 30 JUN 2011, DOI: 10.1002/wnan.152

  9. Nanomedicines: addressing the scientific and regulatory gap

    Annals of the New York Academy of Sciences

    Volume 1313, Issue 1, April 2014, Pages: 35–56, Sally Tinkle, Scott E. McNeil, Stefan Mühlebach, Raj Bawa, Gerrit Borchard, Yechezkel (Chezy) Barenholz, Lawrence Tamarkin and Neil Desai

    Version of Record online : 27 MAR 2014, DOI: 10.1111/nyas.12403

  10. Nanomedicine and personalised medicine: understanding the personalisation of health care in the molecular era

    Sociology of Health & Illness

    Mathieu Noury and José López

    Version of Record online : 26 OCT 2016, DOI: 10.1111/1467-9566.12502

  11. Prudent Precaution in Clinical Trials of Nanomedicines

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 831–840, Gary E. Marchant and Rachel A. Lindor

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00711.x

  12. Is the European Medical Products Authorisation Regulation Equipped to Cope with the Challenges of Nanomedicines?

    Law & Policy

    Volume 33, Issue 2, April 2011, Pages: 276–303, BÄRBEL R. DORBECK-JUNG and NUPUR CHOWDHURY

    Version of Record online : 8 MAR 2011, DOI: 10.1111/j.1467-9930.2011.00339.x

  13. Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 856–864, Gurumurthy Ramachandran, John Howard, Andrew Maynard and Martin Philbert

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00714.x

  14. Nanomedicine and ethics: is there anything new or unique?

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 3, Issue 2, March/April 2011, Pages: 111–118, Todd Kuiken

    Version of Record online : 20 APR 2010, DOI: 10.1002/wnan.90

  15. Nanomedicine First-in-Human Research: Challenges for Informed Consent

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 823–830, Nancy M. P. King

    Version of Record online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00710.x

  16. Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers

    Advanced Materials

    Volume 23, Issue 36, September 22, 2011, Pages: H217–H247, Forrest M. Kievit and Miqin Zhang

    Version of Record online : 15 AUG 2011, DOI: 10.1002/adma.201102313

  17. Perspectives and potential applications of nanomedicine in breast and prostate cancer

    Medicinal Research Reviews

    Volume 33, Issue 1, January 2013, Pages: 3–32, Yang Liu, Metasebya Solomon and Samuel Achilefu

    Version of Record online : 9 NOV 2010, DOI: 10.1002/med.20233

  18. Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 2, February 2014, Pages: 168–178, V Krishnan and A K Rajasekaran

    Version of Record online : 5 SEP 2013, DOI: 10.1038/clpt.2013.174

  19. You have free access to this content
    Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling

    British Journal of Pharmacology

    Volume 171, Issue 17, September 2014, Pages: 3963–3979, Darren Michael Moss and Marco Siccardi

    Version of Record online : 2 JUL 2014, DOI: 10.1111/bph.12604

  20. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 5, Issue 2, March/April 2013, Pages: 111–129, Bengt Fadeel, Neus Feliu, Carmen Vogt, Abuelmagd M. Abdelmonem and Wolfgang J. Parak

    Version of Record online : 17 JAN 2013, DOI: 10.1002/wnan.1206